Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 421
Selected: 0
NCT IDTitle
NCT00068757Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
NCT00002700Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
NCT00061984Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT02982694Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer
NCT00006357STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
NCT00003287Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00389688Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery
NCT00002523Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed
NCT03755856Long-term Outcomes for Acute Myeloid Leukemia Patients
NCT00052312Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
NCT00003772Quality-of-Life Assessment in Patients With Ovarian Cancer
NCT03345095A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
NCT04031872LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)
NCT00017498Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck
NCT00004934Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
NCT01522612Colorectal Cancer (CRC) Cetuximab Elderly Frail
NCT05512364Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT00103168Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
NCT05974774Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
NCT00036868Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT00424060Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
NCT00003589Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00002904Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors
NCT00002916Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer
NCT00014274Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium
NCT02205047Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma
NCT00068744Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
NCT02799706Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer
NCT00041249Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT02929394Trabectedin Maintenance Post 1st-line in STS
NCT00006453Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
NCT00098943NGR-TNF in Treating Patients With Advanced Solid Tumors
NCT00005868Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer
NCT01298388Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998
NCT00003140Letrozole After Tamoxifen in Treating Women With Breast Cancer
NCT00849082Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer
NCT03673735Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC
NCT00003052Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma
NCT02507947SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access
NCT00021450Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
NCT00003976E7070 in Treating Patients With Solid Tumors
NCT00003989ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma
NCT00041236Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma
NCT00053807Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
NCT00004128Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
NCT00006356Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer
NCT00002878Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT01099423Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer
NCT04128072Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
NCT00006354Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy